You are here

Duexis

Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo

Forbes

Thu, 03/15/18 - 09:33 pm

Horizon CEO Tim Walbert knows patients because he is one

Medical Marketing and Media

Wed, 08/23/17 - 11:39 am

autoimmune disease

Access to Horizon Pharma Drugs Cut By Two Leading PBMs

TheStreet.com

Mon, 07/28/14 - 01:17 pm

Horizon Pharma Announces Settlement of Duexis Patent Litigation With Par Pharmaceutical

Healthcare Global

Sat, 08/24/13 - 12:04 pm

Horizon Pharma Enters Settlement Agreements With Par Pharmaceutical

Seeking Alpha

Thu, 08/22/13 - 10:35 am

Par Pharmaceutical

Par Pharmaceutical Sued by Horizon Over Generic Duexis Drug

Bloomberg

Fri, 01/18/13 - 10:09 am

Par Pharmaceutical

Horizon Pharma gets UK nod for arthritis drug

Yahoo/AP

Fri, 12/21/12 - 10:40 am

rheumatoid arthritis

Mallinckrodt Announces Co-Promotion Arrangement for DUEXIS®

Mon, 06/18/12 - 10:59 pm

Mallinckrodt Announces Co-Promotion Arrangement for DUEXIS®

Yahoo

Mon, 06/18/12 - 10:23 am

A $4 Biotech Play Insiders Are Buying Hand Over Fist

Seeking Alpha

Sun, 05/13/12 - 01:03 pm

rheumatoid arthritis

2 Attractive Biotech Stocks, With Good Entry Points

Seeking Alpha

Sat, 04/14/12 - 12:21 pm

rheumatoid arthritis

pain management

Horizon Pharma sues Par Pharma over arthritis drug patent

Reuters

Thu, 03/29/12 - 09:57 am

Par Pharmaceutical

The Sun May Not Rise At Horizon Pharma For Duexis

Seeking Alpha

Mon, 12/19/11 - 08:20 am

rheumatoid arthritis

Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States

Yahoo

Thu, 10/13/11 - 10:55 am